We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.99B
AUM Growth
-$13.9M
Cap. Flow
-$131M
Cap. Flow %
-1.88%
Top 10 Hldgs %
60.07%
Holding
150
New
17
Increased
52
Reduced
37
Closed
23

Top Buys

Rank Stock Value
1
ST icon
Sensata Technologies
ST
+$183M
2
CI icon
Cigna
CI
+$17.5M
3
COO icon
Cooper Companies
COO
+$16.5M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.3M
5
BABA icon
Alibaba
BABA
+$10.9M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$228M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$53.3M
3
VTRS icon
Viatris
VTRS
+$20.6M
4
HDB icon
HDFC Bank
HDB
+$16.9M
5
PFE icon
Pfizer
PFE
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 33.54%
2 Healthcare 25.68%
3 Communication Services 15.95%
4 Consumer Discretionary 11.33%
5 Industrials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTLA
76
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.51M 0.05%
77,013
+15,000
+24% +$603K
TVRD
77
Tvardi Therapeutics
TVRD
$22.1M
$3.48M 0.05%
7,968
+222
+3% +$85.8K
WCG
78
DELISTED
Wellcare Health Plans, Inc.
WCG
$3.39M 0.05%
40,000
-15,000
-27% -$1.27M
KANG
79
DELISTED
iKang Healthcare Group, Inc.
KANG
$3.09M 0.04%
+160,000
New +$2.94M
NVDQ
80
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.03M 0.04%
+250,000
New +$2.99M
HUM icon
81
Humana
HUM
$43.5B
$2.83M 0.04%
+14,800
New +$2.75M
CRDF icon
82
Cardiff Oncology
CRDF
$60.7M
$2.83M 0.04%
3,869
+555
+17% +$394K
VRTX icon
83
Vertex Pharmaceuticals
VRTX
$124B
$2.8M 0.04%
22,650
+1,250
+6% +$158K
ENDP
84
DELISTED
Endo International plc
ENDP
$2.79M 0.04%
+35,000
New +$3.02M
BSX icon
85
Boston Scientific
BSX
$68.6B
$2.65M 0.04%
+150,000
New +$2.68M
ATHN
86
DELISTED
Athenahealth, Inc.
ATHN
$2.43M 0.03%
21,222
-10,000
-32% -$1.2M
KTWO
87
DELISTED
K2M Group Holdings, Inc
KTWO
$2.43M 0.03%
101,151
– –
MA icon
88
Mastercard
MA
$502B
$2.24M 0.03%
24,000
– –
ASXC
89
DELISTED
Asensus Surgical, Inc.
ASXC
$1.91M 0.03%
49,013
– –
TD icon
90
Toronto Dominion Bank
TD
$195B
$1.84M 0.03%
34,720
+25,100
+261% +$1.12M
DHR icon
91
Danaher
DHR
$140B
$1.76M 0.03%
30,605
+24,401
+393% +$1.4M
CHRS icon
92
Coherus Oncology
CHRS
$217M
$1.73M 0.02%
+60,000
New +$1.52M
REGN icon
93
Regeneron Pharmaceuticals
REGN
$72.9B
$1.71M 0.02%
3,350
– –
OXFD
94
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.67M 0.02%
120,460
– –
RGLS
95
DELISTED
Regulus Therapeutics
RGLS
$1.53M 0.02%
+1,167
New +$1.88M
JPM icon
96
JPMorgan Chase
JPM
$929B
$1.52M 0.02%
+22,500
New +$1.47M
KITE
97
DELISTED
Kite Pharma, Inc.
KITE
$1.52M 0.02%
25,000
-10,000
-29% -$571K
EIX icon
98
Edison International
EIX
$30.5B
$1.5M 0.02%
26,900
+22,450
+504% +$1.35M
RPRX
99
DELISTED
Repros Therapeutics Inc.
RPRX
$1.43M 0.02%
200,000
– –
SNA icon
100
Snap-on
SNA
$21.4B
$1.29M 0.02%
8,130
+5,950
+273% +$918K
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2015 Portfolio in Review

As of Q2 2015, C WorldWide Group held 150 positions worth $6.99B, down 0.2% from $7B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

C WorldWide Group's Q2 2015 filing shows 17 new, 52 increased, 37 reduced and 23 closed positions. Its largest new stake was Sensata Technologies: 3,260,860 shares worth $172M. The largest sale was Praxair Inc, an estimated $228M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • C WorldWide Group's largest Q2 2015 buy was Sensata Technologies: 3,260,860 shares worth $172M.
  • C WorldWide Group added most to Teva Pharmaceuticals in Q2 2015, an estimated $12.3M increase.
  • C WorldWide Group's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $53.3M.
  • C WorldWide Group fully exited Praxair Inc in Q2 2015, selling an estimated $228M.
  • C WorldWide Group's ten largest holdings make up 60% of its $6.99B portfolio in Q2 2015.
  • C WorldWide Group opened 17 new positions and closed 23 in Q2 2015.
  • C WorldWide Group's portfolio value fell 0.2% quarter-over-quarter to $6.99B.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.